K Hatake Selected Research

K Hatake Research Topics

Disease

5	Neoplasms (Cancer) 12/2016 - 06/2001
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2001 - 03/2000
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017 - 11/2008
3	Sepsis (Septicemia) 03/2019 - 09/2016
3	Leukemia 06/2001 - 09/2000
2	Lymphoma (Lymphomas) 04/2011 - 09/2001
2	Multiple Myeloma 04/2010 - 12/2000
2	Disease Progression 01/2001 - 03/2000
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2017
1	Septic Shock (Toxic Shock Syndrome) 09/2016
1	Drug Eruptions (Drug Eruption) 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2010
1	Erythema Multiforme 07/2010
1	Carcinoma (Carcinomatosis) 06/2010
1	Pleural Effusion (Pleural Effusions) 06/2010
1	Neoplasm Metastasis (Metastasis) 06/2010
1	Hemophilia A (Haemophilia) 08/2008
1	Breast Neoplasms (Breast Cancer) 12/2004
1	Primary Hyperparathyroidism 09/2003
1	Hypercalcemia (Milk Alkali Syndrome) 09/2003
1	Pheochromocytoma 09/2003
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 11/2001
1	Arteritis 11/2001
1	Paraproteinemias (Monoclonal Gammopathy) 08/2001
1	Pain (Aches) 08/2001
1	Colic (Abdominal Cramps) 08/2001
1	Hypoxia (Hypoxemia) 02/2001
1	Hypertension (High Blood Pressure) 01/2001
1	Amyloidosis 12/2000
1	Hypertrophy 12/2000
1	Myeloid Leukemia (Leukemia, Myelocytic) 11/2000
1	Acute Erythroblastic Leukemia (Erythroleukemia) 10/2000

Drug/Important Bio-Agent (IBA)

5	Rituximab (Mabthera)FDA Link 01/2017 - 11/2008
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 12/2000
4	Vincristine (Oncovin)FDA LinkGeneric 01/2017 - 12/2000
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 03/2009
3	Prednisone (Sone)FDA LinkGeneric 01/2017 - 03/2009
3	Proteins (Proteins, Gene)FDA Link 02/2001 - 11/2000
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 03/2019 - 04/2018
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2017 - 03/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2003 - 06/2001
2	Macrophage Colony-Stimulating FactorIBA 11/2001 - 07/2001
2	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2001 - 03/2000
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2001 - 03/2000
2	Hydroxyurea (Hydrea)FDA LinkGeneric 07/2000 - 03/2000
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2016
1	HLA-G Antigens (HLA G)IBA 12/2016
1	Immunoglobulins (Immunoglobulin)IBA 12/2016
1	LigandsIBA 12/2016
1	InterleukinsIBA 09/2016
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2016
1	EndotoxinsIBA 09/2016
1	Bendamustine Hydrochloride FDA Link 01/2016
1	Sorafenib (BAY 43-9006)FDA Link 07/2010
1	Serum AlbuminIBA 06/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2010
1	Galectins (Galectin)IBA 04/2010
1	Peptide Hydrolases (Proteases)FDA Link 04/2010
1	CarbohydratesIBA 04/2010
1	Biomarkers (Surrogate Marker)IBA 11/2008
1	Factor VIII (Coagulation Factor VIII)IBA 08/2008
1	Estrogen ReceptorsIBA 12/2004
1	Tamoxifen FDA LinkGeneric 12/2004
1	Interleukin-8 (Interleukin 8)IBA 09/2003
1	Interleukin-6 (Interleukin 6)IBA 09/2003
1	Parathyroid Hormone-Related ProteinIBA 09/2003
1	CytokinesIBA 09/2003
1	AnthracyclinesIBA 09/2003
1	Indicators and Reagents (Reagents)IBA 11/2001
1	Immunoglobulin A (IgA)IBA 08/2001
1	AclarubicinIBA 07/2001
1	AntibodiesIBA 06/2001
1	Caspase 3 (Caspase-3)IBA 06/2001
1	NF-kappa B (NF-kB)IBA 06/2001
1	DNA (Deoxyribonucleic Acid)IBA 02/2001
1	Erythropoietin FDA Link 02/2001
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2001
1	aldehyde dehydrogenase (NAD(P)+) (acetaldehyde dehydrogenase)IBA 01/2001
1	Ethanol (Ethyl Alcohol)IBA 01/2001
1	Pharmaceutical PreparationsIBA 01/2001
1	InterferonsIBA 12/2000
1	Immunoglobulin G (IgG)IBA 12/2000
1	Interferon-alpha (Interferon Alfa)IBA 12/2000
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 12/2000
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2000
1	Amyloid (Amyloid Fibrils)IBA 12/2000
1	Complement Factor B (Factor B)IBA 11/2000
1	Apoptosis Inducing FactorIBA 11/2000
1	Phosphopyruvate Hydratase (Enolase)IBA 10/2000
1	Messenger RNA (mRNA)IBA 09/2000

Therapy/Procedure

13	Therapeutics 03/2019 - 01/2000
3	Combination Drug Therapy (Combination Chemotherapy) 11/2008 - 07/2001
2	Aftercare (After-Treatment) 07/2000 - 03/2000
1	Transplantation 12/2016
1	Controlled Hypotension 09/2016
1	Drug Therapy (Chemotherapy) 06/2010
1	Mastectomy (Mammectomy) 12/2004
1	Stem Cell Transplantation 09/2001
1	Induction Chemotherapy 01/2001